NERV — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.69

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.16

EPS Last/This Y

1.69

EPS This/Next Y

-0.6

Price

4.5

Target Price

9.5

Analyst Recom

2.33

Performance Q

-42.4

Upside

-22,729.7%

Beta

-0.13

Ticker: NERV

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-18	NERV	4.71	N/A	N/A	0
2026-05-19	NERV	4.34	N/A	N/A	0
2026-05-20	NERV	5.04	N/A	N/A	0
2026-05-21	NERV	5.32	N/A	N/A	0
2026-05-22	NERV	5.25	N/A	N/A	0
2026-05-26	NERV	5.26	N/A	N/A	0
2026-05-27	NERV	5.26	N/A	N/A	0
2026-05-28	NERV	5	N/A	N/A	0
2026-05-29	NERV	4.93	N/A	N/A	0
2026-06-02	NERV	4.78	N/A	N/A	0
2026-06-03	NERV	4.66	N/A	N/A	0
2026-06-04	NERV	4.76	N/A	N/A	0
2026-06-05	NERV	4.97	N/A	N/A	0
2026-06-08	NERV	4.64	N/A	N/A	0
2026-06-09	NERV	4.71	N/A	N/A	0
2026-06-10	NERV	4.69	N/A	N/A	0
2026-06-11	NERV	4.61	N/A	N/A	0
2026-06-12	NERV	4.5	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-18	NERV	4.71	58.1	-	-0.60
2026-05-19	NERV	4.34	58.1	-	-0.60
2026-05-20	NERV	5.05	58.1	-	-0.60
2026-05-21	NERV	5.32	58.1	-	-0.60
2026-05-22	NERV	5.24	97.7	-	-0.20
2026-05-26	NERV	5.21	97.7	-	-0.20
2026-05-27	NERV	5.26	97.7	-	-0.20
2026-05-28	NERV	5.03	97.7	-	-0.20
2026-05-29	NERV	4.93	97.7	-	-0.20
2026-06-01	NERV	4.82	97.7	-	-0.20
2026-06-02	NERV	4.76	97.7	-	-0.20
2026-06-03	NERV	4.68	97.7	-	-0.20
2026-06-04	NERV	4.76	97.7	-	-0.20
2026-06-05	NERV	4.97	97.7	-	-0.20
2026-06-08	NERV	4.66	97.7	-	-0.20
2026-06-09	NERV	4.71	97.7	-	-0.20
2026-06-10	NERV	4.69	97.7	-	-0.20
2026-06-11	NERV	4.62	97.7	-	-0.20
2026-06-12	NERV	4.50	97.7	-	-0.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-18	NERV	0.00	15.72	3.44
2026-05-19	NERV	0.00	15.72	3.44
2026-05-20	NERV	0.00	15.72	3.44
2026-05-21	NERV	0.00	15.72	3.64
2026-05-22	NERV	0.00	15.72	3.64
2026-05-26	NERV	0.00	40.28	3.64
2026-05-27	NERV	0.00	40.28	3.64
2026-05-28	NERV	0.00	40.28	3.25
2026-05-29	NERV	0.00	40.28	3.25
2026-06-02	NERV	0.00	40.16	3.25
2026-06-03	NERV	0.00	40.16	3.25
2026-06-04	NERV	0.00	40.16	3.25
2026-06-05	NERV	0.00	40.16	3.25
2026-06-08	NERV	0.00	40.16	3.25
2026-06-09	NERV	0.00	40.16	3.25
2026-06-10	NERV	0.00	40.16	2.69
2026-06-11	NERV	0.00	40.16	2.69
2026-06-12	NERV	0.00	40.16	2.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

40.16

Beta

-0.13

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.2

Max Drawdown 5-Year %

-94.3

Target Price

9.5

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-29.16

Average EPS Est. Cur. Y

-0.2

EPS Next Y. (Est.)

-0.8

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.35

Return on Equity vs Sector %

135.8

Return on Equity vs Industry %

152.2

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.4

EBIT Estimation

◆ NERV Healthcare

$4.51

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

5/10

Options

0/10

RSI

35.6

Range 1M

16.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

9/30

Estimates

6/20

Inst/Vol

6/15

Options

0/10

EPS Yr

-87%

EPS NY

80.5%

52W%

27.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +110.6% upside

Quality

3/30

Valuation

16/30

Growth

9/25

Stability

8/10

LT Trend

4/5

Upside

+110.6%

Quality

Minerva Neurosciences, Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

NERV

Latest News

—

Caricamento notizie per NERV…

stock quote shares NERV – Minerva Neurosciences, Inc. Stock Price stock today

news today NERV – Minerva Neurosciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NERV – Minerva Neurosciences, Inc. yahoo finance google finance

stock history NERV – Minerva Neurosciences, Inc. invest stock market

stock prices NERV premarket after hours

ticker NERV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NERV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y